About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
In a survey conducted by MMIT, 75% of insurers and middlemen surveyed believe that employers and other plan sponsors that decline accumulator adjustment programs do so because of concerns that the programs can negatively impact patients. Here are highlights from MMIT’s March 2021 “Copay Accumulators and Maximizers: Payer Management Approach” survey performed for PhRMA.
Copay Accumulators and Maximizers: Payer Management Approach image
Report
Cost and Value
Copay Accumulators and Maximizers: Payer Management Approach
Copay Accumulators and Maximizers: Payer Management Approach image